Staff Facultative; Associate Professor
Centro Regional de Hemodonación & University of Murcia
JOSE RIVERA BRIEF CV ORCID: 0000-0003-4225-6840
Education:
1986: Degree in Chemistry (Biochemistry), University of Murcia
1987: MSc, School of Medicine, University of Murcia
1990: PhD and Doctorate Degree, University of Valencia
Research career:
1987-1990 PhD Fellowship, ISCIII, Ministry of Health, Spain
1989 PhD student, Department of Gynecology, University of Oxford
1991-present Staff Chemist, Blood Transfusion Centre, Murcia, Spain
1993- present Associate professor (part time), School of Medicine, University of Murcia.
2015-(6 months): Visiting Investigator (ISCIII grant), Prof. Steve Watson Lab, School of Medicine, University of Birmingham, UK
2008- Present Founder and coordinator of the Spanish group of Inherited Platelet Disorder (GEAP); Coordinator of the Spanish Registry of IPD
2015-Senior investigator of the Murcia Institute of Biomedical research and of Spanish network of rare diseases (CIBERER)
Current position:
Staff Chemist, Blood Transfusion Centre, Murcia, Spain. Head of the Blood Component processing and Quality Management; Head of the Platelet Research group.
Editorial Board member:
Section editor of the journal Platelets
Honors:
Awards for research projects or congress best abstracts by the Spanish Society of Thrombosis and Hemostasis ((different years, last 2021, Best Presentation at the Plenary sesion)
2016-2018 – Co-chair of the SSC-ISTH Platelet Physiology
2019 research grant award form EAHAD
Main domain of research:
Inherited & acquired platelet disorders, antiplatelet therapy; processing and evaluation of platelet products for transfusion.
Recent Publications in the IPD filed. (All publication available at https://orcid.org/0000-0003-4225-6840)
1. Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease. Palma-Baqueros V, et al. Blood Adv. 2022. doi: 10.1182/bloodadvances.2021005446.
2. Expanding the genetic spectrum of TUBB1-related thrombocytopenia. Palma-Barqueros V, et al. Blood Adv. 2021 doi: 10.1182/bloodadvances.2020004057.
3. A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect on platelet function and bleeding diathesis. Palma-Barqueros V, et al. Am J Hematol. 2021. doi: 10.1002/ajh.26076.
Tuesday, July 12, 2022
2:45 PM – 4:00 PM